{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:20:12Z","timestamp":1718583612277},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,16]]},"DOI":"10.7759\/cureus.62485","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T19:56:28Z","timestamp":1718567788000},"source":"Crossref","is-referenced-by-count":0,"title":["Herpes Simplex Virus Necrotic Lymphadenitis Masquerading as Lymphoma"],"prefix":"10.7759","author":[{"given":"Ismail O","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenal","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.12.013","article-title":"Infectious complications of chronic lymphocytic leukemia","volume":"33","author":"Wadhwa PD","year":"2006","unstructured":"Wadhwa PD, Morrison VA. Infectious complications of chronic lymphocytic leukemia. Semin Oncol. 2006, 33:240-9. 10.1053\/j.seminoncol.2005.12.013","journal-title":"Semin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222091","article-title":"Chronic lymphocytic leukaemia with necrotic herpetic adenitis: an elusive clinical condition","volume":"2018","author":"Srivastava R","year":"2018","unstructured":"Srivastava R, Griswold D, Jamil MO. Chronic lymphocytic leukaemia with necrotic herpetic adenitis: an elusive clinical condition. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-222091","journal-title":"BMJ Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb01508.x","article-title":"Generalized lymphadenopathy due to herpes simplex virus type I","volume":"19","author":"Howat AJ","year":"1991","unstructured":"Howat AJ, Campbell AR, Stewart DJ. Generalized lymphadenopathy due to herpes simplex virus type I. Histopathology. 1991, 19:563-4. 10.1111\/j.1365-2559.1991.tb01508.x","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10006","article-title":"Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"68","author":"Joseph L","year":"2001","unstructured":"Joseph L, Scott MA, Schichman SA, Zent CS. Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma. Am J Hematol. 2001, 68:287-91. 10.1002\/ajh.10006","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.DMIH2-0017-2015","article-title":"Herpes simplex virus and varicella-zoster virus","volume":"4","author":"Levin MJ","year":"2016","unstructured":"Levin MJ, Weinberg A, Schmid DS. Herpes simplex virus and varicella-zoster virus. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.DMIH2-0017-2015","journal-title":"Microbiol Spectr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161109","article-title":"Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia","volume":"132","author":"Chang A","year":"2022","unstructured":"Chang A, Sholukh AM, Wieland A, et al.. Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia. J Clin Invest. 2022, 132:10.1172\/JCI161109","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst B","year":"2021","unstructured":"Eichhorst B, Robak T, Montserrat E, et al.. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021, 32:23-33. 10.1016\/j.annonc.2020.09.019","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301241","article-title":"Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A","volume":"7","author":"Eling DJ","year":"2000","unstructured":"Eling DJ, Johnson PA, Sharma S, Tufaro F, Kipps TJ. Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A. Gene Ther. 2000, 7:1210-6. 10.1038\/sj.gt.3301241","journal-title":"Gene Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.1.102.102","article-title":"Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells","volume":"72","author":"Yasukawa M","year":"1988","unstructured":"Yasukawa M, Shiroguchi T, Inatsuki A, Kobayashi Y. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells. Blood. 1988, 72:102-8. 10.1182\/blood.V72.1.102.102","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/his.13137","article-title":"Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature","volume":"70","author":"Salem A","year":"2017","unstructured":"Salem A, Loghavi S, Khoury JD, Agbay RL, Jorgensen JL, Medeiros LJ. Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature. Histopathology. 2017, 70:821-31. 10.1111\/his.13137","journal-title":"Histopathology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24473","article-title":"Histologic transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"91","author":"Agbay RL","year":"2016","unstructured":"Agbay RL, Jain N, Loghavi S, Medeiros LJ, Khoury JD. Histologic transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma. Am J Hematol. 2016, 91:1036-43. 10.1002\/ajh.24473","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2021.12.4.8","article-title":"A review of the Bruton tyrosine kinase inhibitors in B-cell malignancies","volume":"12","author":"Moore DC","year":"2021","unstructured":"Moore DC, Thompson D. A review of the Bruton tyrosine kinase inhibitors in B-cell malignancies. J Adv Pract Oncol. 2021, 12:439-47. 10.6004\/jadpro.2021.12.4.8","journal-title":"J Adv Pract Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01797","article-title":"Ibrutinib with rituximab in first-line treatment of older patients with mantle cell lymphoma","volume":"40","author":"Jain P","year":"2022","unstructured":"Jain P, Zhao S, Lee HJ, et al.. Ibrutinib with rituximab in first-line treatment of older patients with mantle cell lymphoma. J Clin Oncol. 2022, 40:202-12. 10.1200\/JCO.21.01797","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181216","article-title":"Acalabrutinib with rituximab as first-line therapy for older patients with mantle cell lymphoma\u2014a phase II clinical trial","volume":"142","author":"Jain P","year":"2023","unstructured":"Jain P, Chi Young OK, Nastoupil LJ, et al.. Acalabrutinib with rituximab as first-line therapy for older patients with mantle cell lymphoma\u2014a phase II clinical trial. Blood. 2023, 142:3036. 10.1182\/blood-2023-181216","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2","article-title":"Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial","volume":"395","author":"Sharman JP","year":"2020","unstructured":"Sharman JP, Egyed M, Jurczak W, et al.. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial. Lancet. 2020, 395:1278-91. 10.1016\/S0140-6736(20)30262-2","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03355","article-title":"Ascend: Phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemia","volume":"38","author":"Ghia P","year":"2020","unstructured":"Ghia P, Pluta A, Wach M, et al.. Ascend: Phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemia. J Clin Oncol. 2020, 38:2849-61. 10.1200\/JCO.19.03355","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky JA","year":"2013","unstructured":"Dubovsky JA, Beckwith KA, Natarajan G, et al.. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood. 2013, 122:2539-49. 10.1182\/blood-2013-06-507947","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.219220","article-title":"Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus","volume":"105","author":"Blez D","year":"2020","unstructured":"Blez D, Blaize M, Soussain C, et al.. Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus. Haematologica. 2020, 105:478-89. 10.3324\/haematol.2019.219220","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1210::AID-CNCR16>3.0.CO;2-8","article-title":"Herpes lymphadenitis in association with chronic lymphocytic leukemia","volume":"86","author":"Higgins JP","year":"1999","unstructured":"Higgins JP, Warnke RA. Herpes lymphadenitis in association with chronic lymphocytic leukemia. Cancer. 1999, 86:1210-5. 10.1002\/(SICI)1097-0142(19991001)86:7&lt;1210::AID-CNCR16&gt;3.0.CO;2-8","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden LR","year":"2016","unstructured":"Baden LR, Swaminathan S, Angarone M, et al.. Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016, 14:882-913. 10.6004\/jnccn.2016.0093","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247131-herpes-simplex-virus-necrotic-lymphadenitis-masquerading-as-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T19:56:31Z","timestamp":1718567791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247131-herpes-simplex-virus-necrotic-lymphadenitis-masquerading-as-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.62485","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,16]]}}}